Sti

Flere værktøjer

  • Printversion
  • Mindre tekst
  • Større tekst
  • Vælg høj kontrast
  • Vælg version i standardfarver




Registreredes profil

International Drug Policy Consortium

Identifikationsnummer i registret: 75318797051-52
Registreringsdato: 01-11-11 17:02:21

Seneste ændring af oplysningerne om denne organisation 07-10-13 16:49:15
Seneste årlige opdatering 07-10-13 16:49:15


Registrerede: Organisation eller selvstændig

Organisationens navn: International Drug Policy Consortium
Forkortelse: IDPC
Retlig form: Company limited by guarantee
Websted: http://www.idpc.net

Kategorier

Kategori III –Ikke-statslige organisationer
og mere præcist: Ikke-statslige organisationer, platforme og netværk og lignende

Juridisk ansvarlig

Efternavn, Fornavn: Ann Fordham
Stilling: Executive Director

Fast ansvarlig for forbindelser med EU

Efternavn, Fornavn: Mike Trace
Stilling: Chair

Kontaktoplysninger:

Organisationens hovedadresse: City Road, 5th Floor  124-128
EC1V 2NJ London
FORENEDE KONGERIGE, DET
Telefonnr.: (+44) 2073242975
Faxnummer: (+44) 2073242977
Andre kontaktoplysninger: IDPC is a global network of NGOs and professional networks that come together to promote objective and open debate on drug policy issues at the national and international level. We support evidence-based policies that are effective in reducing drug-related harm.

IDPC’s vision is that national and international drug policies are grounded in the principles of human rights and human security, social inclusion, public health, development and civil society engagement.

IDPC intervenes at two levels in the decision making process: We facilitate networking and collaboration between civil society stakeholders, and seek to empower civil society and the most affected populations to better engage with and influence policy making processes. In parallel, IDPC also intervenes directly with high-level policy making processes by providing analysis and expertise to governments and UN agencies on effective and more humane drug policy options.

IDPC members promote the following policy principles in our advocacy work with national governments and international agencies:
1. Drug policies should be developed through a structured and objective assessment of priorities and evidence.
2. All activities should be undertaken in full compliance with international human rights law.
3. Drug policies should focus on reducing the harmful consequences rather than the scale of drug use and markets.
4. Policy and activities should seek to promote the social inclusion of marginalised groups, and not focus on punitive measures towards them.
5. Governments should build open and constructive relationships with civil society in the discussion and delivery of their strategies.

Mål og opgaver

Organisationens mål og opgaver: IDPC is a a global network of NGOs and professional networks that come together to promote objective and open debate on drug policy issues at the national and international level. We support evidence-based policies that are effective in reducing drug-related harm.

IDPC produces briefing papers, disseminates the reports of its member organisations about particular drug-related matters, and offers expert advice to policy makers and officials around the world.

IDPC members have a wide range of experience and expertise in the analysis of drug problems and policies, and have contributed to policy debates at national and international level.

We have two main objectives:
- We provide channels for grassroots organisations to better engage with policy making processes: we facilitate communication and cooperation between civil society stakeholders, and we produce and disseminate information and materials on more effective and humane drug policies, that national and local NGOs can use in their own work. We also organise capacity building trainings to support the drug policy advocacy work of NGOs. In order to facilitate civil society engagement, we organise our work regionally.

- We draw on the knowledge within our network to offer expert advice to policy makers on how best to review their drug policies at the national and international level. The IDPC network includes many individuals who have experience of creating or reviewing government drug policies and strategies, and these individuals are available to engage in high-level discussions with policy makers.
Organisationen har interesser på:
  • nationalt plan
  • europæisk plan
  • verdensplan

Antal personer, der udfører aktiviteter, der falder ind under åbenhedsregistrets anvendelsesområde

Antal personer: 8
Supplerende oplysninger: IDPC staff includes six full time and two part-time staff members. We also hire consultants around the world who work on thematic or regional issues related to drug policy. For more information on the IDPC team, please visit: www.idpc.net/team.

Personer akkrediteret ved Europa-Parlamentet

Ingen akkrediterede

Aktiviteter

De vigtigste EU-initiativer, der blev dækket af aktiviteter, der falder ind under registrets anvendelsesområde, foregående år:


Over the past two years, under a grant from the European Commission Drug Prevention and Information Programme, IDPC conducted a number of activities in Western and South East Europe. Throughout 2010-2011, IDPC created a dynamic network of NGOs from South East Europe to promote exchange of information and experience among professionals in the field of drug policy in the region. We also produced a number of publications focused on South East Europe and Western European countries.

Since April 2011, IDPC has been involved in a project funded by the European Commission in collaboration with the Transnational Institute and other European NGOs. This project aims to promote exchange of experience through informal drug policy dialogues, expert seminars and the drafting of expert publications on issues related to the European Union and European countries.

IDPC also shares evidence and best practice from the EU and its member states in international forums, such as the Commission on Narcotic Drugs (CND), through the organisation of side events, the dissemination of materials and direct meetings with government delegations.

IDPC is also an active member of the European Commission Civil Society Forum on Drugs where we have engaged in drug policy debates regarding the European Union Drug Strategy and its Action Plans. Individually, IDPC has also watched closely the drafting of the new EU Drug Strategy for 2013-2020 and the Action Plan for 2013-2016. We has provided a set of recommendations, as well as organised a seminar at the European Parliament in May 2012 to ensure open discussions among representatives of EU institutions and international experts on the direction of EU drug policy for the coming years.

Interesseområder for e-mails med underretning om høringer og køreplaner;

Organisationens interesseområder:
  • Eksterne forbindelser
  • Folkesundhed
  • Indre Anliggender
  • Kommunikation
  • Regionalpolitik
  • Retlige Anliggender og grundlæggende rettigheder
  • Transeuropæiske net  
  • Unge

Struktur

"Fysiske personer" i alt: 106
Antal medlemsorganisationer
Medlemsorganisationer (Antal personer) :
Organisationen har medlemmer eller er repræsenteret i følgende land(e):
  • BELGIEN
  • BULGARIEN
  • DANMARK
  • FORENEDE KONGERIGE, DET
  • FRANKRIG
  • GRÆKENLAND
  • IRLAND
  • ITALIEN
  • KROATIEN
  • LITAUEN
  • NEDERLANDENE
  • POLEN
  • PORTUGAL
  • RUMÆNIEN
  • SLOVENIEN
  • SPANIEN
  • SVERIGE
  • TYSKLAND
  • UNGARN

  • ALBANIEN
  • AMERIKAS FORENEDE STATER
  • ARGENTINA
  • AUSTRALIEN
  • BOLIVIA
  • BOSNIEN-HERCEGOVINA
  • BRASILIEN
  • CANADA
  • CHILE
  • COLOMBIA
  • COSTA RICA
  • FORENEDE ARABISKE EMIRATER, DE
  • GEORGIEN
  • INDIEN
  • INDONESIEN
  • KENYA
  • LIBANON
  • MAKEDONIEN, DEN TIDLIGERE JUGOSLAVISKE REPUBLIK
  • MALAYSIA
  • MAURITIUS
  • MEXICO
  • MONTENEGRO
  • NEW ZEALAND
  • PERU
  • RUSSISKE FØDERATION, DEN
  • SAINT LUCIA
  • SCHWEIZ
  • SERBIEN
  • THAILAND
  • TUNISIEN
  • UGANDA
  • URUGUAY
  • VIETNAM
Supplerende oplysninger: The IDPC has two types of membership. Partner members work together to implement the annual IDPC work plan, while network members contribute to the dissemination of our ideas and materials. We come together to facilitate open debate on drug policy issues, and to promote more humane and effective policy at a national and international level.

For a full list of IDPC Partner Members, please visit: http://idpc.net/members/partners

For a full list of IDPC Network Members, please visit: http://idpc.net/members/network

For more information on IDPC's membership criteria, please visit: http://idpc.net/members/membership-criteria

Netværk

Information om foreninger eller sammenslutninger, organisationen er medlem af, og/eller netværk, den indgår i .




IDPC is a member of the European Civil Society Forum on Drugs, and of the Vienna NGO Committee on Drugs.

Finansielle oplysninger

Regnskabsår: 04/2012 - 03/2013
Samlet budget: 747.446
heraf offentlig finansiering: 345.360
- fra europæiske kilder:
- Offentlige kontrakter:
- Tilskud: 21.861
- fra nationale kilder: 323.499
- fra lokale/regionale kilder:
anden finansiering: 402.086
- tilskud:
- medlemsbidrag:
grants (OSF, Getty Foundation, AUSAID, AMFAR, RCNF) : 402.086
Anslåede omkostninger forbundet med organisationens direkte lobbyvirksomhed i EU-institutionerne i det pågældende regnskabsår: >= 50000  € og < 100000  €
Eventuelle andre finansielle oplysninger og yderligere relevant information:


Adfærdskodeks

Organisationen har ved registrering accepteret åbenhedsregistrets adfærdskodeks.